Iressa (Gefitinib)



Gefitinib is a drug practiced for several breast, lung, and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which prevents signaling through the epidermal cancer factor receptor in target cells.


There are no reviews yet.

Be the first to review “Iressa (Gefitinib)”

Your email address will not be published. Required fields are marked *